Naloxone Spray Global Market is Booming Across the Globe and Witness Huge Growth By Key Players To 2033 | Pfizer Inc., Adapt Pharma Inc., NextDistro Inc., Rite Aid Corporation, Novartis International AG

The naloxone spray market size has grown exponentially in recent years. It will grow from $540.68 billion in 2023 to $668.6 billion in 2024 at a compound annual growth rate (CAGR) of 23.7%. The growth in the historic period can be attributed to increased prevalence of opioid overdose, rising cases of opioid drug abuse in developed countries, advancements in drug development, increasing awareness about the importance of naloxone spray, growing healthcare expenditure.

The naloxone spray market size is expected to see exponential growth in the next few years. It will grow to $1592.93 billion in 2028 at a compound annual growth rate (CAGR) of 24.2%. The growth in the forecast period can be attributed to supportive government initiatives for naloxone distribution, expansion of naloxone accessibility programs, rising prescription rates for opioid analgesics, ongoing concerns and efforts to combat opioid crisis. Major trends in the forecast period include adoption of intranasal naloxone formulations, development of user-friendly naloxone devices, integration of naloxone education in opioid prescribing practices, inclusion of naloxone in community-based harm reduction programs.

Market Overview -
Naloxone spray refers to a substance that binds to opioid receptors and inhibits or reverses the actions of other opioids. Giving naloxone quickly undoes the effects of opioid medications, returning breathing to normal. It may be given intravenously or through nasal spray. Naloxone comes as a solution (liquid) to spray into the nose and each naloxone nasal spray contains a single dose of naloxone and should be used only once.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=5339&type=smp

Rising Opioid Overdose Epidemic Propels Naloxone Spray Market Expansion
The increase in the prevalence of opioid overdoses is contributing to the growth of the naloxone spray market. Opioids include medicines such as morphine, fentanyl, and trama*dol and are used for the treatment of pain. However, due to their pharmacological effects, their non-medical use, prolonged use, misuse, and use without medical supervision can lead to opioid dependence, cause breathing difficulties, or even lead to death or other health problems. For instance, in February 2021, according to a report published by the Centers for Disease Control and Prevention (CDC), opioids were involved in 49,860 overdose deaths (or 70.6% of all drug overdose deaths). As a part of emergency medical treatment, naloxone nasal spray is used to reverse the life-threatening effects of an opia*te or opioid overdose. Therefore, the increasing prevalence of opioid overdoses drives the growth of the naloxone spray market.

Competitive Landscape -
Major companies operating in the naloxone spray market report are Emergent BioSolutions Inc., Amphastar Pharmaceuticals Inc., Hikma Pharmaceuticals plc, Indivior plc, Nasus Pharma LLC, Neon Laboratories Limited, Opiant Pharmaceuticals Inc., Pfizer Inc., Samarth Pharma Pvt. Ltd., Teva Pharmaceutical Industries Ltd., Troikaa Pharmaceuticals Ltd., Adapt Pharma Inc., AmerisourceBergen Corporation, Cardinal Health Inc., CVS Health Corporation, Express Scripts Holding Company, Harm Reduction Coalition Inc., Kaleo Inc., McKesson Corporation, Mundipharma International Limited, Mylan N. V., NextDistro Inc., Rite Aid Corporation, Novartis International AG, Sandoz International GmbH, Fresenius Kabi USA LLC, Hospira Inc., West-Ward Pharmaceuticals Corp., Walgreens Boots Alliance Inc., Lupin Ltd.

Product Approvals Driving Expansion In The Naloxone Spray Market
The increase in product approvals is shaping the naloxone spray market. Major companies manufacturing naloxone sprays are focused on new product approvals to broaden their product portfolios and expand their naloxone spray business. For instance, in April 2021, the US Food and Drug Administration (FDA) approved Hikma Pharmaceuticals KLOXXADOTM (naloxone hydrochloride) nasal spray 8mg, for the immediate treatment of recognized or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, in adult and pediatric patients. KLOXXADOTM provides an important new treatment to address the opioid epidemic and contains twice as much naloxone per spray as Narcan Nasal Spray 4mg in a ready-to-use nasal spray to reverse the effects of opioid overdose.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/naloxone-spray-global-market-report

Key Segments -
The naloxone spray market covered in this report is segmented -
1) By Dosage: 2 mg/Actuation, 4 mg/Actuation
2) By Distribution Channel: Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, Other distribution channels

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.